fda glp-1 warning news november 2025 Trends In FY Letters With FDA approval of Wegovy

A 2026 systematic review in the European Journal of Endocrinology found GLP-1 receptor agonists were associated with modest short-term weight loss in women with PCOS and overweight or obesity

Lawsuits filed across the country, including multidistrict litigation in federal court, allege that pharmaceutical companies like Novo Nordisk and Eli Lilly failed to properly warn patients and healthcare providers about these dangers

This has led medical professionals to explore the use of GLP-1 medications (glucagon-like peptide-1 agonists), which are currently FDA-approved for diabetes control, weight management, and reducing cardiovascular risks

[47] Low vitamin concentrations in human milk occur in families with low socioeconomic status or low consumption of animal products

Good food. If you dont have a genuine deficiency, you already have all the amino acids you need from a decent diet

Consultation with a Naturopathic Doctor or other primary care provider is recommended for anyone suffering from a health problem